Compound 18a5
Compound 18a5 is a lead small molecule for triple-negative breast cancer (TNBC) research, functioning through targeted degradation of Annexin A3 (ANXA3) . It has demonstrated promising activity in both in vitro cellular assays and in vivo xenograft models, supporting its investigation as a potential therapeutic agent.
Product Specifications
Field of Research
Pharmacology & Drug Discovery
Smiles
O=C (CSC (NC1C (N (C (C) C) C (C=CC=C2) =C2C (C3=CC=CC=C3) =N1) =O) =S) N (CC4) CCN4C5=NC=CC=C5
Molecular Formula
C30H32N6O2S2
Molecular Weight
572.74
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb3114428 100 µg
Metabotropic Glutamate Receptor 5/GRM5 Rabbit Polyclonal Antibody (Fluoro550)
Sign In for Pricing
View Details 
K6068306 1.0 µg DNA
Vom2r5 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1)
Sign In for Pricing
View Details